Matrix metalloproteinases are zinc-containing endopeptidases that degrade the extracellular matrix (18) , playing an important role in wound repair (4) and arthritis (12) . Of great interest is the involvement of stromelysins, which are the metalloproteinases with the widest substrate specificities (20) , in tumor invasion and metastasis. Thus, transformed cells with high metastatic potential produce high levels of stromelysin, whereas nonmetastatic tumor cells do not (2, 24, 27) . Stromelysin expression is induced by mitogens (10, 15, 19) , oncogenes like ras (10) , and inflammatory cytokines (21) . All of these factors trigger signal transduction pathways that are being progressively better understood. In this regard, mitogens, inflammatory cytokines, or the activation of ras has been shown to stimulate a number of kinase cascades that transmit the information generated at the proximity of the plasma membrane to the nucleus where different transcription factors are stimulated (14) . The cascade initiated by the activation of Raf-1 is by far the best known. Once activated, Raf-1 phosphorylates MEK which activates MAPK that in turn phosphorylates and stimulates, among others, the important transcription factor p62 TCF (1) . There is another important pathway that is stimulated by growth factor and stress signals and that culminates in the activation of a new member of the MAPK family, named SAPK or JNK (6, 16 ). SAPK appears to be activated by another kinase called SEK, which is analogous to MEK (22) and that is activated by MEK kinase, the mammalian homolog of the yeast Ste11 (28) . The activation of SAPK leads to the specific phosphorylation of c-Jun at serines 63 and 73 within the trans-activation domain (13) . Recently Deng and Karin (5) reported the activation by ras of another novel kinase named FRK that phosphorylates and activates c-Fos and that presumably is controlled by upstream kinases (5) . In this context, it is noteworthy that we have recently demonstrated that the isoform of protein kinase C (PKC) is critically involved in the control of cell proliferation, most probably through the activation of the MEK-MAPK pathway (9) . Interestingly, a PKC dominant negative mutant but not a Raf-1 dominant negative mutant blocks the stimulation of the stromelysin promoter activity in response to platelet-derived growth factor (23) . Therefore, it seems that downstream of PKC there is a bifurcation of signalling cascades: one shared with Raf-1 that is channelled by MAPK and another specific for PKC that culminates in the activation of stromelysin (9) .
The characterization of the stromelysin promoter region demonstrated that an element (SPRE) located between nucleotides Ϫ1221 and Ϫ1203 is necessary and sufficient for the control of stromelysin gene expression in response to mitogen stimulation (10, 23) . Following mitogenic activation of fibroblasts, the induction of a factor binding to this sequence was detected by mobility shift assays (23) . Using a concatenated probe with several copies of this element to screen a gt11 cDNA expression library from mouse Swiss 3T3 fibroblasts, we have isolated a novel protein (SPBP) of 937 amino acids that binds this element in the stromelysin promoter and has several features of a transcription factor. In fact, the transfection of an expression plasmid for SPBP activates transcription of a reporter chloramphenicol acetyltransferase (CAT) gene containing either the full-length stromelysin promoter or a single copy of the SPRE cloned upstream of the herpes simplex virus thymidine kinase minimal promoter. Therefore, these results describe a novel transcription factor critically involved in the control of the stromelysin promoter activity.
MATERIALS AND METHODS
Oligonucleotides. The following oligonucleotides were synthesized by Isogen Biosciences (Amsterdam, The Netherlands): primer A (5Ј-CTAGAATTCCC AGCTCCATTATAAGAGA-3Ј), primer B (5Ј-TGGTCTAGAATCTGCAGAA CCTTC-3Ј), primer C (5Ј-ATACCCGGGATGCGGCGGGTCCCTGGTA-3Ј), primer D (5Ј-GTGAGAACATAGGAAGGAAG-3Ј), primer RACE1 (5Ј-CAG GAATTCGGTCTTAGCAGGACTTGTCA-3Ј), primer RACE2 (5Ј-TACGA  ATTCTGGATGACTGTGCAGACTCGG-3Ј), primer RACE3 (5Ј-CTGGAA  TTCCATCTGTCTCTTATAATGGAG-3Ј), primer HA1 (5Ј-AGCTTGCCGC  CACCATGTATGATGTTCCTGATTATGCTAGCCTCCCGGGG-3Ј), primer  HA2 (5Ј-ATTCCCCGGGAGGCTAGCATAATCAGGAACATCATACATGG  TGGCGGCA-3Ј), and anchor primer (5Ј-CTGGTTCGGCCCACCTCTGAA  GGTTCCAGAATCGATAG-3Ј) .
gt11 cDNA expression library screening. The library of mouse Swiss 3T3 fibroblast cDNAs constructed in the expression vector gt11 was purchased from Clontech Laboratories, Inc. The standard gt11 host strain Y1090 was employed to screen gt11 recombinants. Plating mixtures for 150-mm-diameter plates contained a maximum of 5 ϫ 10 4 PFU of phage. Infected Y1090 cells were plated in 0.7% agarose and incubated overnight at 42ЊC. The nitrocellulose filters were saturated with 10 mM isopropyl-␤-D-thiogalactopyranoside (IPTG) for 30 min. The IPTG-saturated nitrocellulose filter overlays were incubated for 6 h at 37ЊC. Plates were cooled at 4ЊC for 10 min before the filters were lifted off the plates. After the positions of the filters on the plates were marked, a second IPTG-saturated filter was incubated for 3 h at 37ЊC. The filters were lifted off the plates and immediately immersed in aliquots (50 ml per filter) of BLOTTO (5% nonfat milk powder, 50 mM Tris [pH 7.5], 50 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol [DTT] ) and incubated for 60 min at 4ЊC with gentle shaking. In this and all subsequent steps, each filter was incubated in a separate petri plate with protein surface turned up. Filters were rapidly transferred from one solution to another to prevent drying. Filters were washed twice (5 min for each wash) with an aliquot (50 ml per filter) of TNE-50 (10 mM Tris [pH 7.5], 50 mM NaCl, 1 mM EDTA, 1 mM MgCl 2 , 1 mM DTT). After these washes, the filters were incubated, for screening, in 50 ml of TNE-50 containing 32 P-binding site probe, a concatenated probe with multiple SPRE binding sites (1 ϫ 10 6 to 2 ϫ 10 6 cpm/ml), labelled as described below, and 5 g of denatured DNA carrier per ml overnight at 4ЊC with gentle shaking. The filters were washed three times (a total of 25 min) with 500 ml for 10 filters in TNE-50 at room temperature. They were dried and exposed to Kodak film (12 to 24 h) with an intensifying screen at Ϫ70ЊC. Binding site probe for gt11 library screening. A concatenated probe containing multiple SPRE binding sites (nucleotides Ϫ1221 to Ϫ1203, in the stromelysin promoter) was generated to screen a gt11 cDNAs expression library. First, the 5Ј termini of two complementary strands of a synthetic oligonucleotide were separately phosphorylated in a 10ϫ kinase-ligase buffer (500 mM Tris-HCl [pH 7.6], 100 mM MgCl 2 , 100 mM ATP, 50 mM DTT) with 2 l of T4 polynucleotide kinase (8 U/l) for 1 h at 37ЊC in a final volume of 50 l. The phosphorylated complementary strands were then annealed by incubating the mixture (100 l) for 2 min at 85ЊC, 15 min at 65ЊC, 15 min at 37ЊC, 15 min at room temperature, and 15 min on ice. The probe was concatenated by the addition of 4 l of T4 DNA ligase (1 Weis unit/l) and 1 l of 50 mM ATP and incubating the mixture for 12 h at 16ЊC. The concatenated probe was labelled with [␣- DNA-DNA library screening. The library of mouse Swiss 3T3 fibroblast cDNAs constructed in the gt11 vector was screened by a standard method by using the partial cDNA clone 1 (1.5 kb) previously isolated as the probe; this clone was labelled by random primer. Approximately 1.2 ϫ 10 6 phage were screened by plaque hybridization. The host strain Y1090 was infected with recombinant phage and replicated on Hybond-Nylon filters (Amersham). Filters were UV cross-linked and then prehybridized in a prehybridization solution (50% formamide, 3ϫ Denhardt's solution, 5ϫ SSC [1ϫ SSC is 0.15 M NaCl plus 0.015 M sodium citrate], 0.05 M NaPO 4 H Ϫ buffer [pH 6.5], 100 g of denatured salmon sperm DNA per ml) at 42ЊC. Denatured probe was added to the hybridization solution (50% formamide, 3ϫ Denhardt's solution, 5ϫ SSC, 0.05 M NaPO 4 H Ϫ buffer [pH 6.5], 0.1% dextran sulfate, and 100 g of denatured salmon sperm DNA per ml) and incubated at the same temperature overnight. Filters were washed in 2ϫ SSC-0.1% sodium dodecyl sulfate (SDS) at room temperature twice (10 min each time) and then in the same solution at 50ЊC twice (25 min each time). The cDNA clone isolated was subcloned into pBluescript-KS vector (Stratagene). DNA sequencing was performed with Sequenase (U.S.B.-Amersham) and the KS and T7 primers as well as a variety of synthetic oligonucleotides, and all the sequences were determined in both strands.
Rapid amplification of cDNA ends (RACE) with a 5-RACE-ready cDNA. To obtain the 5Ј end of the incomplete cDNA, a mouse brain 5Ј-RACE-Ready cDNA (Clontech Laboratories, Inc.) was used as the template in PCR with the RACE1 and anchor primers. The conditions of the PCR were as follows: 30 PCR cycles, with 1 cycle consisting of 45 s at 94ЊC, 45 s at 60ЊC, and 2 min at 72ЊC, with a final extension step of 7 min at 72ЊC. This RACE reaction yielded clone 3. This clone was used in a second RACE reaction as the template and with RACE2 and anchor primers. This procedure generated clone 4, which in a third RACE reaction with primers RACE3 and anchor resulted in clone 5. Clones 3, 4, and 5 were subcloned into the EcoRI site of pBluescript-KS, and DNA sequences were determined in both strands.
PCR. Clone 6 was amplified from 1 l of mouse fibroblast cDNA (10 9 PFU/ ml) from the cDNA library with primers A and B. The cDNAs were incubated at 70ЊC for 5 min prior PCR. All PCRs described in this report contained 10 mM Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl 2 , 200 M concentrations of each of the four deoxynucleoside triphosphates, 100 pmol of each primer, 2.5 U of AmpliTaq (Perkin-Elmer Cetus). The conditions for PCRs were as follows: 30 PCR cycles, with 1 cycle consisting of 1 min at 94ЊC, 2 min at 55ЊC, and 3 min at 72ЊC, with a final 7-min extension step at 72ЊC. Clone 7 resulted from a PCR with the overlapping templates: clones 5 and 6 and primers C and B. Clone 8 was amplified from a PCR with clones 6 and 7 as the templates and with primers C and D.
Plasmid generation, protein expression, and antibody production. Plasmids palCAT and pHB1CAT have been described elsewhere (23) . Plasmid palMUT1CAT contains one copy of the mutated pal sequence (MUT1; 23) inserted into the BamHI site of pBLCAT2, which contains the herpes simplex virus thymidine kinase minimal promoter. pHB1MUT1CAT was obtained by site-directed mutagenesis (Clontech Laboratories, Inc.) with the following mutagenic oligonucleotide: 5Ј-AAAGACATTTTAAATGTAGTATTCTATGGT-3Ј.
The full-length coding region (clone 8; 731 to 3710 bp) was subcloned into the EcoRV site of pcDNA3HA vector to generate plasmid pCDNA3HA-SPBP. To construct pCDNA3HA vector, primers HA1 and HA2 were annealed and ligated into pCDNA3 (Invitrogen) digested with HindIII and EcoRI. In order to make pCDNA3HA-SPBP ⌬ZIP , clone 1 (1897 to 3387 bp) was subcloned into the EcoRV site of pCDNA3HA. Clone 1 was also subcloned into the EcoRI site of pMAL-c2 (New England Biolabs). An MBP-clone 1 fusion protein was expressed in Escherichia coli JM101 and purified by binding to amylose resin, according to the manufacturer's instructions (New England Biolabs). Anti-SPBP antiserum was raised in rabbits with this fusion protein.
Transfection and gene expression assays. NIH 3T3 fibroblasts were seeded at a density of 300,000 cells per 60-mm-diameter dish and maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. Twenty-four hours later, cells were transfected during a 4-h period with 10 g of total DNA (5 g of plasmid and 5 g of carrier calf thymus or 5 g of each plasmid cotransfected) in calcium phosphate. Then the medium was changed, and cells were incubated for another 24 h in low (0.2%)-serum medium. After incubation, different stimuli were added according to the experiments, and CAT assays were performed on cell extracts as described previously (23) .
In vitro transcription and translation. The bacteriophage T7 RNA polymerase was used to synthesize sense RNA from plasmid pcDNA3HASPBP in the presence of the cap analog GpppG by using 10 g of linearized DNA as a template (using a transcription kit from Promega). The in vitro SPBP RNA was translated in the rabbit reticulocyte lysate system and treated with nuclease (Promega). Each translation reaction mixture containing 1 g of transcript RNA in a final volume of 50 l was incubated for 1 h at 30ЊC. For radiolabelling, the transcript RNA was translated in a methionine-free amino acid mixture supplemented with [ 35 S]methionine. An aliquot (5 l) of the reaction was added to 20 l of 2ϫ SDS sample buffer and subjected to electrophoresis in an SDS-polyacrylamide gel. The gel was fixed in 50% (vol/vol) methanol-10% (vol/vol) acetic acid for 15 min, treated with Amplify enhancer solution (Amersham) for 15 min at room temperature, dried, and exposed to Kodak film at Ϫ70ЊC for 16 h. For gel shift mobility assays, pcDNA3HASPBP was translated with unlabelled amino acids. An aliquot (7 l) of the reaction mixture was assayed directly in the gel shift mobility assay.
Gel shift mobility assays. Nuclear extracts from NIH 3T3 cells untreated or stimulated with 10% serum for 24 h, were isolated as previously described (7). Nuclear extracts (5 g) were preincubated with preimmune serum or the anti-SPBP antiserum for 15 min at room temperature or with control buffer; the extracts were incubated at room temperature for an additional 30 min with 50,000 cpm of a 32 P-labelled double-stranded synthetic oligonucleotide probe containing the SPRE in the following gel shift binding buffer (5ϫ): 37.5 mM N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid (HEPES; pH 8), 175 mM NaCl, 5 mM MgCl 2 , 0.25 mM EDTA, 2.5 mM DTT, 37.5% glycerol, 4.0 g of poly(dI ⅐ dC), and 3 g of bovine serum albumin. The nuclear protein complexes were separated on a nondenaturing Tris borate-EDTA-5% polyacrylamide gel at 150 V for 3 h. Portions (7 l) of the in vitro-translated protein or of the reticulocyte lysate without RNA were incubated with the concatenated probe in the same gel shift binding buffer for 30 min, and the complexes were separated on a nondenaturing 5% polyacrylamide gel. DNA-binding competition was assessed by preincubating the extracts with a 40-fold molar excess of unlabelled probe.
Northern hybridization. Total RNA from different mouse tissues and quiescent or serum-stimulated NIH 3T3 cells was isolated by the RNAzol B method (Cinna/Biotecx Laboratories Inc., Houston, Tex.). Ten micrograms of each RNA was run on formaldehyde-agarose gels, blotted onto Hybond-Nϩ filters, and hybridized overnight at 42ЊC in a solution containing 5ϫ SSC, 5ϫ Denhardt's solution, 10 mM Tris-HCl (pH 7.5), 0.5% SDS, 50% formamide, 200 g of denatured salmon sperm DNA per ml, and 50 g of tRNA per ml with a 32 P-labelled cDNA probe of SPBP (clone 8). Filters were washed for 15 min at room temperature in 2ϫ SSC, three times (1 h each time) at 56ЊC with 0.1ϫ SSC-0.5% SDS, and for 5 min at room temperature with 2ϫ SSC.
Immunoblot analysis. Proteins (30 g) from quiescent or serum-stimulated NIH 3T3 cells or in vitro-translated proteins were resolved in SDS-10% polyacrylamide gels. Afterwards, they were electrophoretically transferred onto a nitrocellulose filter (Promega) and incubated with preimmune serum or anti-SPBP antibody. Bands were visualized with the ProtoBlot AP System (Promega).
Nucleotide sequence accession number. The GenBank accession number of the SPBP sequence is U20282. A gt11 cDNA expression library from mouse fibroblasts was screened with a concatenated probe containing multiple SPRE binding sites (nucleotides Ϫ1221 to Ϫ1203 in the stromelysin promoter) which resulted in a partial cDNA clone (Fig. 1, clone 1; 1.5 kb) . This clone was used as a probe to rescreen the same library which gave a longer clone (Fig. 1, clone 2; 2.3 kb) ; although still partial, this clone included a stop codon. In order to obtain the missing 5Ј region, a mouse brain 5Ј-RACE Ready cDNA (Clontech Laboratories, Inc.) was used. This procedure yielded a fragment of 354 bp (Fig. 1, clone 3) . On the basis of the sequence of this fragment, the appropriate oligonucleotide was used in a second 5Ј-RACE reaction that produced another 489-bp fragment (Fig. 1, clone 4) . Again on the basis of this sequence, a third 5Ј-RACE reaction that yielded a 1.1-kb fragment (Fig. 1, clone  5) , including the initiation codon and some of the 5Ј untranslated region, was performed. All fragments together represent a cDNA of 3,995 bp ( Fig. 1 and 2) . In order to obtain the whole open reading frame, a PCR was performed with primers A and B (Fig. 1) and the library as the template. This reaction gave a fragment encompassing nucleotides 1016 to 2482 (clone 6; Fig.  1 and 2 ). This fragment was used with that obtained in the third 5Ј-RACE reaction (clone 5) as overlapping templates to perform a PCR with primers C and B. This procedure gave a cDNA fragment encompassing nucleotides 731 to 2482 (clone 7; Fig. 1 and 2 ). This fragment was used with clone 2 as overlapping templates and primers C and D to perform a PCR that yielded a cDNA fragment (clone 8; Fig. 1 and 2 ) that begins at nucleotide 731 (initiation codon) and ends at nucleotide 3710 and that includes the stop codon (nucleotide 3542). This cDNA (clone 8) was subcloned into the appropriate plasmids for further studies.
Protein structure, molecular weight, and tissue distribution. The full-length cDNA clone is composed of a total of 3,995 nucleotides (Fig. 2) . Sequence analysis revealed the presence of an open reading frame of 2,822 bp, which is defined by a potential ATG initiation codon (nucleotides 731 to 733) and a TGA stop codon (nucleotides 3542 to 3544) and is flanked by 730 (5Ј) and 453 (3Ј) untranslated nucleotide sequences. A stop codon TGA (nucleotides 638 to 640) is found in frame upstream of the initiation codon. This open reading frame encodes a protein of 937 amino acids (Fig. 2) , with a predicted molecular mass of 103 kDa, from now on termed SPBP for SPRE-binding protein. This sequence was used to search the EMBL, GenBank, and SwissProt data banks with the FSTP-SCAN program of the PCgene package. No obvious similarity to any other protein or gene was detected. Therefore, SPBP is a novel protein. The Prosite analysis of its sequence reveals three potentially important signatures. A bipartite nuclear localization signal (amino acids 266 to 283), one domain that conforms to the consensus sequence for a leucine zipper (ZIP; amino acids 182 to 203), and a basic region (amino acids 595 to 611) highly homologous to the DNA-binding domain reported for the Fos-Jun family of transcription factors (17) . The SPBP basic region was 47% identical at the amino acid level to those of mouse c-Fos and FosB and 41% identical to mouse c-Jun (26) (Fig. 3B) . The putative ZIP domain consists of four leucines spaced at intervals of seven residues (Fig. 3A) , and helical wheel analysis confirms the segregation of these leucines on one face (not shown). In consideration of all this, SPBP could be an atypical transcription factor of the ZIP-basic type. However, there are two important differences between SPBP and the members of the AP-1 family: its large size (937 amino acids) and the fact that in contrast to Fos or Jun, the putative ZIP domain is separated from the basic region by a relatively long amino acid stretch (391 amino acids). These features make SPBP a potentially novel (and with an atypical structure) transcription factor. Results described in the next sections below strongly indicate that this is actually the case. In vitro transcription and translation of clone 8 produced a major band with a molecular mass of around 110 kDa, consistent with the predicted protein sequence (Fig. 4A) . A cDNA fragment encoding amino acids 390 to 897 was subcloned into the pMAL vector to prepare an MBP-fusion protein that was bacterially expressed and obtained 95% pure. This protein was used to immunize rabbits and generate an antibody that recognizes a band of around 110 kDa in an immunoblot of extracts from NIH 3T3 fibroblasts (Fig. 4B) . The molecular mass of that band is identical to that observed in the in vitro translation experiment (Fig. 4A) . Actually, Western blot (immunoblot) analysis of the in vitro-translated SPBP recognizes the same band as in Fig. 4A (not shown). Northern (RNA) blot analysis was done with RNAs derived from different tissues and NIH 3T3 cells stimulated by 10% serum (Fig. 5 ). SPBP appears to be expressed at different levels mainly in fibroblasts and in the heart, kidneys, and brain. Two major RNA transcripts of 7.4 and 5.8 kb were detected in all these tissues.
Induction of SPBP by serum. Previous studies demonstrated the induction by mitogens and PKC of a nuclear factor SPRE binding activity (23) . Therefore, it would be of interest to determine whether serum induces SPBP in quiescent NIH 3T3 fibroblasts. Immunoblot analysis of extracts from cells incubated with 10% serum for 2 to 4 h displayed a significantly higher SPBP content than those of parallel cultures kept in serum-free medium (Fig. 6A) . This increase in the amount of SPBP protein correlates with a higher SPBP RNA content in serum-activated cultures than in cells incubated in serum-free medium (Fig. 6B) . Note that the SPBP protein is in the nucleus and that the stimulation by or the starvation of serum does not alter its subcellular distribution (not shown). The fact that SPBP is induced following a mitogenic stimulus is in keeping with the notion that it could be at least one component of the serum-induced SPRE nuclear binding activity (23) . To address this possibility, nuclear extracts from quiescent or serum-activated NIH 3T3 cells were analyzed by gel shift mobility assays using the 32 P-labelled double-stranded SPRE probe described previously (23) . Nuclear extracts were incubated either with control buffer, preimmune serum, or the anti-SPBP antiserum described above, prior to the addition of the labelled probe. Results from Fig. 7 demonstrate that nuclear extracts from serum-treated cells displayed a SPRE nuclear binding activity that is not seen in nuclear extracts from serum-starved cells, in agreement with early data (23) . Interestingly, preincubation with the anti-SPBP antiserum, but not with the preimmune serum or with the buffer control, abolished the serum-induced SPRE nuclear binding activity (Fig. 7) . This result indicates that SPBP is at least one critical component of that nuclear factor activity. Consistent with this are the results of the following experiment, in which the ability of in vitro-translated SPBP to bind a 32 P-labelled SPRE probe (23) in a gel shift mobility assay was determined. Note that in vitro-translated SPBP forms a DNA-binding complex with the 32 P-labelled SPRE probe that is inhibited by an excess of cold oligonucleotide and inhibited by preincubation with the anti-SPBP antibody, but not by the preimmune serum (Fig. 8) . When in P-labelled SPRE in which the palindrome sequence ACTAGT was disrupted (MUT1 in reference 23), no DNA-binding complex was formed (not shown). This is in keeping with the fact that the palindrome is required for the binding of the mitogenactivated SPRE nuclear factor activity and that SPBP is a critical component of that factor.
Transfection of an SPBP expression vector transactivates SPRE and the stromelysin promoter. To test the functional activity of SPBP in vivo, we used CAT reporter plasmids containing either a single copy of the SPRE sequence (palCAT; 23) (or a mutant that disrupts the palindrome [palMUT1CAT, based on the oligonucleotide MUT1 in reference 23; see above] cloned upstream of a minimal promoter) or the fulllength stromelysin promoter (pHB1CAT; 23) (or a mutant of this promoter in which the mutations of MUT1 were introduced in the SPRE [pHB1MUT1CAT]). When transfected into NIH 3T3 cells, palCAT and pHB1CAT gave high levels of CAT enzyme activity in the presence of 10% serum (23) . Cotransfection of a eukaryotic expression vector for the fulllength SPBP with plasmid palCAT (Fig. 9A ) or plasmid pHB1CAT (Fig. 9B) produced in quiescent cells levels of CAT activity comparable to those obtained by serum stimulation. This result indicates that expression of SPBP is sufficient to transactivate a minimal promoter containing a single copy of the SPRE, as well as the full-length stromelysin promoter. It is of great interest that deletion of amino acids 1 to 389, which includes the putative ZIP region, abolishes the ability of SPBP to transactivate palCAT and pHB1CAT, and more importantly, this mutant displays a dominant negative effect because it blocks the ability of serum to activate both CAT reporter plasmids (Fig. 9) . Results from Fig. 9 indicate that mutations in the SPRE that disrupt the palindrome severely inhibit the ability of SPBP to transactivate both reporter plasmids.
DISCUSSION
Matrix metalloproteinases, and specifically stromelysin, have been shown to play a crucial role in physiopathologic processes, such as tumor metastasis (2, 24, 27) . Stromelysin expression is induced by mitogens (10, 19) , inflammatory cytokines (21) , and oncogenes like ras (10) . The region in the stromelysin promoter that is important for its activation (SPRE) is a novel sequence located between nucleotides Ϫ1221 and Ϫ1203 that binds a nuclear factor that can be induced in response to mitogenic activation (23) . Here we report the cloning and molecular characterization of a novel transcription factor (SPBP) that is a critical component of that nuclear SPRE binding activity. This protein displays potential features found in the members of the AP-1 family of transcription factors. Thus, SPBP has a putative leucine zipper domain and a basic region with homology to the DNA basic domains of Fos and Jun. However, there are important differences between SPBP and Fos or Jun. Thus, whereas Fos and Jun have molecular masses of around 30 kDa, SPBP has a molecular mass of 110 kDa. This is reminiscent of the relationship existing between the transcription factor SREBP-1, involved in the regulation of the cellular metabolism of cholesterol, and the basic-helix-loop-helix (bHLH)-ZIP class of DNA-binding proteins (29) . Thus, although both have a bHLH-ZIP domain, SREBP-1 is much larger than the other bHLHL-ZIP proteins. But what makes SPBP really intriguing is that whereas in Jun and Fos the ZIP region and the basic DNA-binding domain are very close, in SPBP both domains are separated by a long stretch of amino acids. This finding probably implies a novel 
, together with either plasmid palCAT or palMUT1CAT (A) or plasmid pHB1CAT or pHB1MUT1CAT (B) by the calcium phosphate precipitation method. After 4 h, the DNA-containing medium was removed, and cells were incubated with low (0.2%)-serum medium for 24 h. Afterwards, cells were either untreated (empty bars) or stimulated with 10% serum (hatched bars) and extracts were prepared and CAT activity was determined as described in Materials and Methods. Results are the means Ϯ standard deviations of four independent experiments with incubations in duplicate.
VOL. 15, 1995 SPRE-BINDING PROTEIN 3169 mechanism of regulation and/or activation. Also of note is the fact that whereas in Fos and Jun the basic DNA-binding domain precedes the ZIP in the sequence, in the case of SPBB, the ZIP is located closer to the amino terminus than the putative basic DNA-binding domain. The ZIP region in Fos or Jun is critical for dimerization, which in turn regulates transcriptional activity (14, 25) . We do not know yet whether SPBP has to dimerize to be functional, but a mutant that lacks the putative ZIP region is not active and, furthermore, blocks the activation of the stromelysin promoter by mitogens. This, together with the fact that the simple transfection of an SPBP expression vector is sufficient to promote transactivation of CAT reporter plasmids with a single copy of SPRE or the full-length stromelysin promoter suggests that homodimerization may be important for SPBP activity. However, it is possible that SPBP levels are limiting and that its synthesis provokes the formation of heterodimers with preexisting factors necessary for SPBP function. Either model would be consistent with the results presented in this study showing that SPBP is actually increased following mitogenic stimulation. Recent preliminary results suggest that Fos and Jun may not be components of the SPRE nuclear factor binding activity (not shown), suggesting that most probably Fos and Jun do not interact with SPBP. Whatever the mechanism, the report presented here undoubtedly constitutes a significant advance in the understanding of stromelysin expression and gene transcription in general, because it identifies a novel transcription factor whose characterization will permit one to trace the signalling cascades implicated in its induction and regulation. It is noteworthy that PKC has been shown to be specifically and critically involved in the activation of stromelysin expression through the promoter sequence to which SPBP binds (23) . This is of great relevance because PKC is an important step in mitogenic signal transduction (3, (7) (8) (9) 11) . Further experiments will help to elucidate whether phosphorylation of SPBP by PKC or PKC-activated kinases is important for the regulation of its transcriptional activity.
